Teacher Retirement System of Texas acquired a new stake in UiPath Inc. (NYSE:PATH – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 26,935 shares of the healthcare company’s stock, valued at approximately $446,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Diversified Trust Co lifted its holdings in UiPath by 23.2% in the 2nd quarter. Diversified Trust Co now owns 17,067 shares of the healthcare company’s stock valued at $283,000 after purchasing an additional 3,218 shares in the last quarter. Renaissance Capital LLC lifted its holdings in UiPath by 16.1% in the 2nd quarter. Renaissance Capital LLC now owns 145,673 shares of the healthcare company’s stock valued at $2,414,000 after purchasing an additional 20,184 shares in the last quarter. FDx Advisors Inc. lifted its holdings in UiPath by 19.4% in the 2nd quarter. FDx Advisors Inc. now owns 27,712 shares of the healthcare company’s stock valued at $459,000 after purchasing an additional 4,501 shares in the last quarter. AdvisorNet Financial Inc increased its stake in shares of UiPath by 64.8% in the 2nd quarter. AdvisorNet Financial Inc now owns 5,110 shares of the healthcare company’s stock worth $85,000 after acquiring an additional 2,010 shares during the last quarter. Finally, Xponance Inc. increased its stake in shares of UiPath by 165.7% in the 2nd quarter. Xponance Inc. now owns 43,152 shares of the healthcare company’s stock worth $715,000 after acquiring an additional 26,910 shares during the last quarter. Hedge funds and other institutional investors own 59.04% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on PATH shares. Canaccord Genuity Group raised their target price on UiPath from $19.00 to $21.00 and gave the stock a “buy” rating in a research note on Thursday, September 7th. Mizuho raised their target price on UiPath from $16.00 to $18.00 and gave the stock a “neutral” rating in a research note on Thursday, September 7th. Bank of America raised their target price on UiPath from $20.00 to $22.00 in a research note on Thursday, September 7th. Barclays raised their price objective on UiPath from $16.00 to $18.00 in a research report on Thursday, September 7th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $19.00 price objective on shares of UiPath in a research report on Thursday, September 28th. Nine equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, UiPath presently has an average rating of “Hold” and an average price target of $19.84.
Insider Activity
In other news, CFO Ashim Gupta sold 40,000 shares of UiPath stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $15.52, for a total value of $620,800.00. Following the completion of the transaction, the chief financial officer now owns 1,344,047 shares in the company, valued at approximately $20,859,609.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Rich Wong sold 100,000 shares of the business’s stock in a transaction that occurred on Friday, September 22nd. The stock was sold at an average price of $16.38, for a total transaction of $1,638,000.00. Following the completion of the sale, the director now owns 779,693 shares in the company, valued at $12,771,371.34. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Ashim Gupta sold 40,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $15.52, for a total value of $620,800.00. Following the sale, the chief financial officer now owns 1,344,047 shares of the company’s stock, valued at approximately $20,859,609.44. The disclosure for this sale can be found here. In the last quarter, insiders sold 220,000 shares of company stock worth $3,691,600. 31.03% of the stock is currently owned by company insiders.
UiPath Price Performance
Shares of UiPath stock opened at $15.39 on Friday. The business has a 50-day moving average of $16.30 and a 200 day moving average of $16.38. UiPath Inc. has a 12 month low of $10.40 and a 12 month high of $19.94. The stock has a market capitalization of $8.72 billion, a price-to-earnings ratio of -48.09 and a beta of 0.59.
UiPath (NYSE:PATH – Get Free Report) last announced its quarterly earnings data on Wednesday, September 6th. The healthcare company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.05. The business had revenue of $287.31 million during the quarter, compared to analysts’ expectations of $281.48 million. UiPath had a negative return on equity of 7.49% and a negative net margin of 15.47%. The business’s quarterly revenue was up 18.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.18) EPS. Equities research analysts anticipate that UiPath Inc. will post -0.28 earnings per share for the current year.
UiPath Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
- Five stocks we like better than UiPath
- Best Stocks Under $10.00
- MarketBeat Week in Review – 10/9 – 10/13
- How to Buy Bitcoin Stock: 3 Easy Ways to Do It
- What BlackRock’s Earnings Tell You About The Stock Market Tide
- Basic Materials Stocks Investing
- Sociedad Quimica y Minera de Chile Well Positioned Lithium Stock
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
